Table 1.
Descriptive characteristics of all adults with cerebral palsy, and differences between Gross Motor Function Classification System (GMFCS) I-III and IV-V
| Total Sample | GMFCS I-III | GMFCS IV-V | p-value | |
|---|---|---|---|---|
| N |
112 |
58 |
54 |
|
| Female. O |
53.6 |
51.4 |
52.0 |
0.805 |
| Age On) |
34.00 (13.41) |
32.95 (13.63) |
36.10 (18.01) |
0.224 |
| Race/Ethnicity, % |
|
|
|
|
| Non-Hispanic White |
90.4 |
87.9 |
92.3 |
0.45 |
| African American |
7.8 |
10.3 |
5.8 |
0.39 |
| Mexican American or Other Hispanic |
1.7 |
1.7 |
1.9 |
0.94 |
| Body Mass (kg) |
61.73 (25.09 |
72.35 (22.51) |
51.02 4.73) |
<0.001* |
| Recumbent Length (cm) |
159.21 (13.35) |
161.65 (9.90) |
155.68 (16.27) |
0.043* |
| Body Mass Index (kg∙m-2) |
25.86 (7.59) |
28.72 (7.41) |
22.79 (634) |
<0.001* |
| Obesity (BMI≥30), % |
23.5 |
32.1 |
14.00 |
0.04* |
| Waist Circumference (cm) |
85.53 (20.48) |
92.80 (17.47) |
79.20 (22.14) |
0.003* |
| Hip Circumference (cm) |
93.75 (17.23) |
101.19 (1 3.10) |
85.06 (18.57) |
<0.001* |
| Waist-to-Hip Ratio |
0.90 (0.09) |
0.90 (0.10) |
0.90 (0.08) |
0.74 |
| 25-hydroxyvitanin D (25(OH)D) (ng/mL) |
30.17 (15.02) |
27.53 (11.68) |
31.71 (11.40) |
0.143 |
| Parathvroid hormone (PTH). (pg/mI) | 49.8 (26.65) | 47.96 (25.10) | 52.63 (28.86) | 0.418 |
*Significant difference between GMFCS I-III and IV-V (p <0.05).